Conolidine’s analgesic consequences stem from its conversation with non-opioid pain pathways. Unlike opioids, which bind to µ-opioid receptors inside the central nervous procedure, conolidine modulates alternate molecular targets. A Science Developments analyze identified that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availab... https://robertl741srd0.howeweb.com/profile